Budget Amount *help |
¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
Fiscal Year 2015: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2014: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Antibodies are expected to be used as potential anticancer drugs. Recently, it is reported that recombinant antibody, 5A3 recognizes Man3. However, only amino acid sequences of 5A3 were already investigated. In this study, fragment molecular orbital (FMO) calculations were performed to get insight into the mechanism of Man3-recognition of 5A3. Prior to the FMO calculations, 3D structures of the complex was investigated using induced-fit docking simulations between six structures of 5A3 and 141 conformers of Man3. Finally, amino acid residues of 5A3 contributing to Man3-recognition were proposed.
|